Rx/Reimbursement Adult Incontinence in Belgium
Demand increased during 2022, with a couple of key drivers behind this growth. Firstly, the country's ageing population continued to drive ongoing demand for RX/reimbursement adult incontinence. In addition, the demand for reimbursement for adult incontinence increased due to the high inflation and the financial turmoil experience by some Belgians in 2022. On June 1st, 2022, the reimbursement amount was increased due to inflation. The allocation is now EUR177.24 for non-dependent and EUR543.02 f...
Euromonitor International's Rx/Reimbursement adult incontinence in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Rx/Reimbursement Adult Incontinence in Belgium
- Euromonitor International
- March 2023
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN BELGIUM
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Higher demand driven by rising inflation during 2022
- Ontex Global benefits from being the main supplier in Belgium
- PROSPECTS AND OPPORTUNITIES
- Overall stable demand driven by the ageing population
- The government will continue to raise awareness of entitlement to reimbursement
- CATEGORY DATA
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2022-2027
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2022-2027
- TISSUE AND HYGIENE IN BELGIUM
- EXECUTIVE SUMMARY
- Tissue and hygiene in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- MARKET INDICATORS
- Table 5 Birth Rates 2017-2022
- Table 6 Infant Population 2017-2022
- Table 7 Female Population by Age 2017-2022
- Table 8 Total Population by Age 2017-2022
- Table 9 Households 2017-2022
- Table 10 Forecast Infant Population 2022-2027
- Table 11 Forecast Female Population by Age 2022-2027
- Table 12 Forecast Total Population by Age 2022-2027
- Table 13 Forecast Households 2022-2027
- MARKET DATA
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2018-2022
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2019-2022
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2017-2022
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2017-2022
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2022
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2022-2027
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2022-2027
- DISCLAIMER
- SOURCES
- Summary 1 Research Sources